Califf Nomination Could Show Confidence In Bipartisan Appeal
This article was originally published in The Tan Sheet
Executive Summary
After seven months as deputy commissioner for medical products and tobacco, Robert Califf is nominated as FDA commissioner. The nomination goes through the Senate Health, Education, Labor and Pensions Committee before heading to the floor for a full Senate vote.
You may also be interested in...
FDA Lands Califf As Top Deputy, Potential Next Commissioner
Renowned cardiologist and clinical trial researcher Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco. Califf is director of Duke University’s Translational Medicine Institute and vice chancellor for Clinical and Translational Research.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Parallel Scientific Advice: Is The EMA User Fee Impacting Interest?
EMA charges participants to receive scientific advice through the fledgling program, unlike the US FDA, which may not fit the budgets of some complex generic sponsors. At the same time, sponsors also may simply not be aware the program exists yet.